INTRODUCTION
============

Phthalate esters (PEs) are widely used as plasticizers in commercial products for polyvinyl chloride (PVC) [@B002]. Despite the recent scientific interest on the potential human effects of phthalates, their toxicities have not been clearly characterized. An important concern about phthalate esters relates to their potential to act as reproductive toxicans in rodent species. This compound causes apoptosis and the loss of spermatogenic cells, resulting in testicular atrophy [@B014]; [@B024]; [@B032]. For example, the perinatal exposure to di (2-ethylhexyl) phthalate (DEHP) or di (n-butyl) phthalate (DBP) inhibits the production of testicular testosterone in the fetus. These compounds dmasculinizes the males in that they display a reduced anogenital distance (AGD) , retained nipples, a cleft phallus with a hypospadias, undescended testes, a vaginal pouch, epididymal agenesis, and small to absent sex accessory glands as adults [@B010]; [@B012]; [@B019].

Initial experiments implicated only phthalate diester-mediated toxicity, but the toxicity of phthalate monoester, a primary metabolite, was not assessed. The phthalate monoesters are formed as metabolites from the phthalate diester by various tissue enzymes in mammals [@B004]; [@B020]; [@B022]. DEHP administered to rodents is metabolized to mono (2-ethylhexyl) phthalate (MEHP) and 2-ethylhexanol as the major metabolites [@B013], and the butylbenzyl phthalate (BBP) administered to rats is metabolized to monobenzyl phthalate (MBeP) and monobutyl phthalate (MBuP) [@B005]; [@B017]. MBuP is also formed as a major metabolite in rats given DBP [@B001]; [@B030]. In addition, dimethyl phthalate (DMP) and diethyl phthalate (DEP) are metabolized to their corresponding monoesters, monomethyl phthalate (MMP) and monoethyl phthalate (MEP) [@B018].

In order to examine the adverse effects of PEs on human health, the urinary excretion levels of phthalate monoesters were measured [@B003]. Although PEs did not show any genotoxicity, there is some evidence suggesting that they can cause systemic toxicity at high concentrations [@B007]; [@B008]; [@B023]. It has been demonstrated that the reproductive toxicity observed in animals exposed to certain PEs may be due in part to estrogenic or anti-androgenic effects [@B009]; [@B026]; [@B035]. However, the short term toxicity of various PEs, including DEHP, DBP, or BBP as well as their monoesters, MEHP, MBuP or MBeP, have yet to be evaluated in their comparative toxicity.

The present study investigated the comparative short term toxicity of nine phthalate diesters in Sprague-Dawley rats, which are commonly present in the environment, five phthalate monoesters and PA, which can be derived from the diesters.

MATERIALS AND METHODS
=====================

Chemicals.
----------

Phthalate diesters including DEHP, DBP, di-n-octylphthalate (DnOP) , DEP, BBP, DMP, di-isodecyl phthalate (DIDP) , diundecyl phthalate (DUP) , and diisononyl phthalate (DINP) and phthalate monoesters including MEHP, MBuP, MBeP, MEP, mono-methyl phthalate (MMP) , and PA were purchased from Sigma (St. Louis, MO, USA) , Aldrich (Milwaukee, WI, USA) , Fluka (Steinheim, Germany) , Wako (Osaka, Japan) or Tokyo Kasei Kogyo Co. (TKK, Tokyo, Japan) , respectively.

Experimental animals and treatments.
------------------------------------

Sprague-Dawley male rats (at four weeks) were purchased from Charles River Laboratories (Japan) and housed under specific pathogen-free (SPF) conditions. They were housed in clear polycarbonate cages with wood chips for bedding and given a pellet rodent diet and water ad libitum. The animals were maintained under controlled conditions (23 ± 3℃, humidity 55 ± 5%, ventilation frequency ≥ 15 cycles/hr, and under a 12 hr light/dark cycle) , and they were examined for any clinical signs and weighed at predetermined intervals. After one week of acclimatization, animals were randomly allocated to groups based on their body weight. As shown in [Fig. 1](#F001){ref-type="fig"}, the phthalate diesters (500 mg/kg bw/day) , phthalate monoesters and PA (250 mg/kg bw/day) were administered by an oral gavage. The control group was given the vehicle (corn oil) orally. Experimental protocols were approved by the institutional animal ethics committee of Korea Food and Drug Administration.

![The used PEs and metabolites used in the present study. The alkyl- or alkylaryl-diesters are hydrolyzed to form monoesters.](toxicr-26-75-g001){#F001}

Clinical signs, mortality, dietary consumption, and body and organ weights.
---------------------------------------------------------------------------

The animals were observed thoroughly for the onset of any immediate toxic signs and were examined throughout the observation period to record any delayed acute effects and mortality. The animals were observed once each day after administering the test chemicals for four weeks. All of the rats were weighed on days 0, 3, 6, 9, 12, and 14 (two-week repeated study) . The mean body weight was calculated in the animals that survived up to the end of the period. The dietary consumption in the groups was measured at the beginning of the treatment and twice a week during the two weeks. Under anesthesia, the following vital organs including the heart, lung, liver, kidney, adrenal glands, spleen, thymus, thyroid glands, testes and epididymides were weighed, and the organ-to-body weight ratios were calculated.

Blood and urine analysis.
-------------------------

During the autopsy, the whole blood taken from all of the rats in each group was allowed to clot, the serum was separated and the blood samples for hematological analysis were collected into CBC bottles containing EDTA. The red blood cell (RBC) count, hemoglobin (Hb) concentration, hematocrit (Ht) , mean corpuscular volume (MCV) , mean corpuscular hemoglobin (MCH) , mean corpuscular hemoglobin concentration (MCHC) , platelet (PLT) count and white blood cell (WBC) count were determined using a Coulter counter T-540 (Coulter Counter Electronics, USA) . For serum biochemistry analysis, blood samples were centrifuged at 3000 rpm for 10 min within 1 h after collection. The sera were stored at -80℃ freezer before analysis. The levels of serum biochemistry parameters including calcium, potassium, sodium, albumin, blood urea nitrogen (BUN) , cholesterol, triglyceride (TG) , creatinine, glucose, total cholesterol, total bilirubin, total protein,alkaline phosphatase (ALP) , aspartate aminotransferase (AST) , alanine aminotransferase (ALT) , γ-gluamyl transferase (GGT) and creatine phosphokinase (CPK) were measured using an autoanalyzer, model Hitachi 7170 (Hitachi, Tokyo, Japan) .For urine analysis, six rats from each group were placed in urine-collection cages without food and water, and the 12-h urine outputs were collected. The occult blood, pH, protein, urobilinogen, glucose, nitrite, bilirubin, ketone bodies, leukocytes and urine specific gravity were measured using a Multi-Stick (Miles-Sankyo Co., Tokyo, Japan) and with an Atago Serum Protein Refractometer N (Atago Co., Tokyo, Japan) .

Statistical analysis.
---------------------

The quantitative differences between the control and treatment groups in terms of the body and organ weights, sperm counts and motility, blood hematology, serum biochemistry and urine parameters were analyzed by a one-way ANOVA. A Dunnett's test (*P* \< 0.05) was applied for a pair-wise comparison between the control and treatment groups.

RESULTS
=======

Clinical signs, mortality, body weight and food consumption.
------------------------------------------------------------

No animals died during the PE administration period until two weeks (data not shown) . Salivation was observed immediately after administering most PEs in all animals (data not shown) . The body weights of animals in the DBP-, DINP-, BBP-, MEHP-, MBuP- and PA-treated groups were significantly decreased after the two-week administration periods ([Fig. 2](#F002){ref-type="fig"}) , whereas there were no significant differences in food consumption between the treatment groups and control throughout the study (data not shown) .

![The body weight changes following the administration of the vehicle control (corn oil) and phthalate esters (diesters, 500mg/kg bw/day; monoesters, 250mg/kg bw/day) to Sprague-Dawley male rats for two weeks (A, phthalate diesters; B, phthalate monoesters) . The data is expressed as the mean ± SD, as calculated for ranges of five to six rats. \* Significantly different from the control group at P \< 0.05. \*\* Significantly different from the control group at P \< 0.01.](toxicr-26-75-g002){#F002}

Relative organ weights.
-----------------------

The relative liver weights in the DEHP-, DBP-, DnOP- and DIDP-treated groups were significantly higher than those in the controls. The relative testes weights were significantly decreased in the DEHP-,DnOP-, DIDP- and DUP-treated groups but not in any other PEs. The thymus weights were significantly lower than the controls in the MEHP-treated group only. There were no significant differences in the relative weights of the thyroid, lung, heart, spleen, kidney, adrenal gland and epididymis in any of the PE groups ([Table 1](#T001){ref-type="table"}) .

Hematology.
-----------

The WBC levels were significantly lower in the DEHP- and DINP-treated groups, but there were no significant differences, and all of the values were within the normal range ([Table 2](#T002){ref-type="table"}) .

###### 

Relative organ weights of Sprague-Dawley rats orally treated with phthalate esters for 2 weeks

  -------- --------------- ------------- ----------------- ------------- ------------------- ------------- ----------------- ------------------ ----------------- ---------------------
           Thyroid         Lung          Thymus            Heart         Liver               Spleen        Kidney (paired)   Adrenal (paired)   Testis (paired)   Epididymis (paired)
                                                                                                                                                                  
  CON^a^   0.006 ± 0.001   0.58 ± 0.26   0.20 ± 0.07       0.37 ± 0.01   2.84 ± 0.07         0.26 ± 0.03   0.38 ± 0.02       0.010 ± 0.003      0.759 ± 0.084     0.103 ± 0.012
  DEHP     0.006 ± 0.002   0.55 ± 0.05   0.25 ± 0.04       0.41 ± 0.05   4.45 ± 0.39^\*\*^   0.29 ± 0.03   0.40 ± 0.02       0.010 ± 0.003      0.676 ± 0.065\*   0.104 ± 0.013
  DBP      0.007 ± 0.001   0.49 ± 0.04   0.19 ± 0.04       0.39 ± 0.04   3.19 ± 0.15^\*^     0.27 ± 0.02   0.37 ± 0.01       0.013 ± 0.003      0.672 ± 0.044     0.107 ± 0.009
  DnOP     0.007 ± 0.002   0.50 ± 0.03   0.25 ± 0.05       0.39 ± 0.03   3.32 ± 0.32^\*^     0.26 ± 0.03   0.38 ± 0.02       0.009 ± 0.003      0.627 ± 0.050\*   0.103 ± 0.015
  DEP      0.007 ± 0.002   0.52 ± 0.06   0.22 ± 0.02       0.40 ± 0.06   3.13 ± 0.15         0.29 ± 0.03   0.38 ± 0.03       0.010 ± 0.002      0.635 ± 0.020     0.103 ± 0.007
  BBP      0.006 ± 0.002   0.59 ± 0.07   0.19 ± 0.08       0.40 ± 0.02   3.14 ± 0.22         0.29 ± 0.03   0.40 ± 0.03       0.012 ± 0.003      0.700 ± 0.021     0.112 ± 0.015
  DMP      0.007 ± 0.002   0.48 ± 0.06   0.21 ± 0.02       0.39 ± 0.03   2.79 ± 0.11         0.25 ± 0.03   0.37 ± 0.03       0.011 ± 0.003      0.739 ± 0.061     0.111 ± 0.011
  DIDP     0.008 ± 0.002   0.53 ± 0.04   0.22 ± 0.02       0.43 ± 0.10   3.69 ± 0.46^\*\*^   0.28 ± 0.02   0.39 ± 0.02       0.009 ± 0.002      0.623 ± 0.074\*   0.101 ± 0.005
  DUP      0.006 ± 0.002   0.52 ± 0.06   0.24 ± 0.05       0.38 ± 0.03   3.19 ± 0.17         0.26 ± 0.02   0.37 ± 0.01       0.009 ± 0.001      0.630 ± 0.040\*   0.099 ± 0.005
  DINP     0.006 ± 0.001   0.50 ± 0.06   0.17 ± 0.09       0.39 ± 0.04   3.32 ± 0.13         0.27 ± 0.03   0.39 ± 0.02       0.011 ± 0.001      0.652 ± 0.057     0.116 ± 0.008
  MEHP     0.005 ± 0.002   0.54 ± 0.10   0.12 ± 0.07^\*^   0.46 ± 0.03   3.48 ± 0.43^\*^     0.24 ± 0.05   0.39 ± 0.03       0.014 ± 0.004      0.678 ± 0.069     0.104 ± 0.015
  MBuP     0.006 ± 0.001   0.61 ± 0.04   0.14± 0.10        0.38 ± 0.05   3.14 ± 0.27         0.25 ± 0.03   0.40 ± 0.02       0.012 ± 0.002      0.672 ± 0.060     0.106 ± 0.016
  MBeP     0.007 ± 0.004   0.46 ± 0.02   0.21 ± 0.03       0.38 ± 0.04   2.54 ± 1.16         0.24 ± 0.02   0.40 ± 0.02       0.010 ± 0.002      0.694 ± 0.061     0.111 ± 0.012
  MEP      0.007 ± 0.001   0.57 ± 0.16   0.19 ± 0.02       0.39 ± 0.03   2.69 ± 0.23         0.27 ± 0.02   0.35 ± 0.02       0.012 ± 0.002      0.745 ± 0.055     0.120 ± 0.019
  MMP      0.006 ± 0.000   0.47 ± 0.05   0.23 ± 0.06       0.37 ± 0.03   2.86 ± 0.18         0.25 ± 0.05   0.37 ± 0.03       0.010 ± 0.001      0.665 ± 0.079     0.103 ± 0.014
  PA       0.007 ± 0.000   0.55 ± 0.11   0.17 ± 0.04       0.38 ± 0.03   2.90 ± 0.29         0.24 ± 0.05   0.39 ± 0.02       0.012 ± 0.001      0.737 ± 0.052     0.114 ± 0.010
  -------- --------------- ------------- ----------------- ------------- ------------------- ------------- ----------------- ------------------ ----------------- ---------------------

Data are means ± SD (n = 6 animals) .

^a^Treated with corn oil.

^\*^Significantly different from the control group at *P* \< 0.05.

^\*\*^Significantly different from the control group at *P*\<0.01.

###### 

Hematological values of Sprague-Dawley rats orally treated with phthalate esters for 2 weeks

  -------- ------------------- ------------------- -------------- -------------- -------------- -------------- -------------- -------------------
           WBC (10^3^/mm^3^)   RBC (10^6^/mm^3^)   Hb (g/dl)      Ht (％)        MCV (μ^3^)     MCH (pg)       MCHC (g/dl)    PLT (10^3^/mm^3^)
                                                                                                                              
  CON^a^   6.45 ± 2.46         7.58 ± 0.48         15.22 ± 0.66   48.73 ± 1.58   64.43 ± 2.22   20.10 ± 0.43   31.22 ± 0.53   653.83 ± 82.54
  DEHP     5.40 ± 1.35         6.95 ± 0.33         15.82 ± 0.76   46.28 ± 1.97   66.66 ± 1.83   19.90 ± 0.71   29.84 ± 0.82   634.00 ± 82.29
  DBP      6.30 ± 0.89         7.67 ± 0.31         15.52 ± 0.43   49.60 ± 1.33   64.72 ± 1.43   20.26 ± 0.29   31.28 ± 0.43   691.00 ± 68.08
  DnOP     6.28 ± 1.45         7.29 ± 0.16         14.73 ± 0.27   48.32 ± 1.15   66.28 ± 1.82   20.22 ± 0.16   30.48 ± 0.65   663.17 ± 73.18
  DEP      6.26 ± 0.87         6.84 ± 0.18         14.12 ± 0.34   46.44 ± 0.56   67.98 ± 2.59   20.68 ± 0.80   30.40 ± 0.62   672.00 ± 46.51
  BBP      5.96 ± 1.68         7.81 ± 0.45         15.45 ± 0.63   49.70 ± 1.58   63.73 ± 2.10   19.78 ± 0.63   31.08 ± 0.72   646.67 ± 53.66
  DMP      7.83 ± 2.75         7.87 ± 0.48         15.90 ± 0.66   50.38 ± 1.76   64.17 ± 3.56   20.23 ± 0.62   31.57 ± 0.99   671.17 ± 59.73
  DIDP     6.14 ± 0.32         7.18 ± 0.14         14.66 ± 0.24   48.78 ± 0.34   67.96 ± 1.57   20.42 ± 0.49   30.06 ± 0.57   713.80 ± 52.48
  DUP      5.32 ± 0.87         7.06 ± 0.30         14.68 ± 0.39   48.87 ± 1.26   66.25 ± 2.80   20.82 ± 0.57   30.07 ± 0.59   678.50 ± 37.63
  DINP     5.16 ± 2.29         7.61 ± 0.59         15.35 ± 1.04   48.75 ± 2.38   64.22 ± 2.62   20.20 ± 0.65   31.48 ± 0.75   602.17 ± 52.61
  MEHP     7.22 ± 5.12         7.91 ± 0.48         15.80 ± 0.94   50.10 ± 2.68   63.38 ± 0.67   19.98 ± 0.17   31.55 ± 0.47   641.75 ± 66.16
  MBuP     6.76 ± 1.66         7.92 ± 0.44         16.16 ± 0.94   50.50 ± 2.14   63.82 ± 1.20   20.40 ± 0.35   31.98 ± 0.54   672.40 ± 55.41
  MBeP     7.66 ± 1.86         7.71 ± 0.26         15.50 ± 0.50   50.37 ± 1.75   65.32 ± 0.97   20.08 ± 0.19   30.77 ± 0.37   655.00 ± 81.90
  MEP      7.85 ± 1.91         7.94 ± 0.19         16.16 ± 0.21   50.76 ± 0.44   63.98 ± 1.45   20.38 ± 0.48   31.82 ± 0.48   680.05 ± 70.43
  MMP      6.88 ± 0.94         7.56 ± 0.37         15.55 ± 0.78   50.32 ± 2.04   66.60 ± 1.38   20.57 ± 0.27   30.88 ± 0.51   719.38 ± 71.16
  PA       6.11 ± 1.28         7.94 ± 0.28         16.18 ± 0.42   50.40 ± 1.90   63.50 ± 0.73   20.42 ± 0.37   32.12 ± 0.53   612.03 ± 98.85
  -------- ------------------- ------------------- -------------- -------------- -------------- -------------- -------------- -------------------

Data are means ± SD (n = 6 animals) .

^a^Treated with corn oil.

###### 

Biochemical serum values of male Sprague-Dawley rats orally treated with phthalate esters for 2 weeks

  -------- -------------------- ----------------- -------------- ----------------- ---------------------- ------------------- ----------------------- ------------------ -------------- --------------------- -------------------- --------------- ---------------- ----------------- -------------------- -------------- ---------------- ----------------- ---------------
           GLU (g/d*l*)         T.P (g/d*l*)      ALB (g/d*l*)   T.BIL (mg/d*l*)   AST (IU/*l*)           ALT (IU/*l*)        ALP (IU/*l*)            T.CHO (mg/d*l*)    GGT (IU/*l*)   TG                    CA (mg/d*l*)         BUN (mg/d*l*)   CREA (mg/d*l*)   CPK (IU/*l*)      LDH                  HDL.C          Na (mEq/*l*)     K (mEq/*l*)       Cl (mEq/*l*)
                                                                                                                                                                                                                                                                                                                                                             
  CON^a^   123.01 ± 20.05       7.03 ± 0.28       2.50 ± 0.09    0.11 ± 0.00       75.67 ± 7.81           41.17 ± 7.03        347.04 ± 49.78          93.54 ± 11.04      0.83 ± 0.02    42.17 ± 7.65          10.23 ± 0.43         17.12 ± 1.41    0.58 ± 0.04      123.17 ± 24.36    83.51 ± 60.40        27.33 ± 2.16   144.47 ± 1.25    4.28 ± 0.32       102.23 ± 1.93
  DEHP     174.33 ± 38.60^\*^   7.05 ± 0.33       2.75 ± 0.10    0.13 ± 0.00       70.57 ± 7.23           61.67 ± 10.02^\*^   532.17 ± 67.67          78.37 ± 8.78^\*^   0.52 ± 0.05    56.67 ± 5.54          11.00 ± 0.44^\*^     19.27 ± 2.63    0.57 ± 0.08      141.02 ± 25.85    148.67 ± 23.63^\*^   33.17 ± 2.79   138.67 ± 1.00    4.82 ± 0.36       97.92 ± 1.10
  DBP      135.22 ± 23.47       7.2 ± 0.08        2.34 ± 0.28    0.12 ± 0.05       96.63 ± 6.77^\*^       54.02 ± 12.11       923.21 ± 82.08^\*\*^    86.66 ± 7.86       1.47 ± 0.04    58.28 ± 7.98          10.88 ± 0.56         15.52 ± 3.35    0.56 ± 0.05      158.45 ± 48.65    135.20 ± 42.71       32.22 ± 3.40   139.46 ± 1.78    4.61 ± 0.82       97.72 ± 1.67
  DnOP     144.05 ± 21.13       7.06 ± 0.28       2.46 ± 0.21    0.16 ± 0.05       83.65 ± 8.46           42.05 ± 8.28        500.40 ± 56.78^\*^      85.22 ± 8.97       1.09 ± 0.00    46.23 ± 4.32          11.18 ± 0.38^\*\*^   15.72 ± 2.20    0.56 ± 0.09      141.23 ± 75.91    130.43 ± 37.42       26.87 ± 1.92   113.52 ± 57.50   3.65 ± 1.78       80.58 ± 42.26
  DEP      140.26 ± 23.47       6.88 ± 0.08       2.48 ± 0.28    0.14 ± 0.05       75.62 ± 6.77           49.81 ± 12.11       415.65 ± 82.08          81.65 ± 7.86       0.85 ± 0.04    42.21 ± 6.98          11.02 ± 0.56^\*^     17.42 ± 3.35    0.54 ± 0.05      168.02 ± 48.65    153.52 ± 22.71^\*^   25.75 ± 3.40   140.32 ± 1.78    5.85 ± 0.82^\*^   98.72 ± 1.67
  BBP      143.33 ± 17.41       6.8 ± 0.28        2.57 ± 0.21    0.13 ± 0.05       79.33 ± 11.20          42.53 ± 6.86        523.07 ± 110.70         80.51 ± 12.01      0.67 ± 0.52    54.00 ± 13.9          10.92 ± 0.23^\*^     18.53 ± 2.25    0.55 ± 0.05      175.51 ± 55.63    129.67 ± 13.76       30.67 ± 5.05   141.07 ± 0.74    4.36 ± 0.78       98.23 ± 0.81
  DMP      141.27 ± 15.47       7.4 ± 0.16        2.32 ± 0.25    0.16 ± 0.13       89.40 ± 11.97          47.62 ± 14.50       764.03 ± 122.48^\*\*^   93.03 ± 4.12       1.04 ± 0.71    50.04 ± 4.00          10.68 ± 0.15         16.06 ± 3.73    0.51 ± 0.00      198.42 ± 159.97   131.03 ± 15.04       31.46 ± 2.51   139.88 ± 1.23    5.42 ± 0.42       100.24 ± 2.06
  DIDP     135.67 ± 19.46       6.92 ± 0.16       2.47 ± 0.16    0.12 ± 0.04       77.67 ± 7.93           51.17 ± 4.44        579.67 ± 57.70^\*^      80.52 ± 6.06^\*^   0.67 ± 0.03    57.52 ± 12.1          10.61 ± 0.44         17.23 ± 1.22    0.55 ± 0.05      116.33 ± 22.50    123.62 ± 15.36       26.84 ± 2.59   140.38 ± 0.99    4.76 ± 0.38       98.98 ± 1.27
  DUP      134.03 ± 18.11       7.67 ± 0.46^\*^   2.25 ± 0.19    0.15 ± 0.05       113.83 ± 15.58^\*\*^   47.17 ± 4.64        626.52 ± 55.83^\*\*^    77.67 ± 8.38^\*^   0.67 ± 0.82    41.17 ± 6.49          10.33 ± 0.43         18.57 ± 2.73    0.55 ± 0.08      138.83 ± 35.52    142.75 ± 12.00       27.25 ± 4.65   116.93 ± 54.88   3.71 ± 1.58       83.45 ± 39.86
  DINP     135.25 ± 16.04       7.04 ± 0.33       2.46 ± 0.46    0.12 ± 0.04       100.02 ± 8.10^\*^      54.45 ± 4.61        902.47 ± 89.69^\*\*^    91.03 ± 7.25       0.6 ± 0.75     64.22 ± 8.14^\*\*^    10.14 ± 0.63         20.68 ± 6.37    0.54 ± 0.05      138.8 ± 27.63     159.8 ± 19.10        32.8 ± 3.27    142.54 ± 1.73    4.85 ± 0.34       99.94 ± 0.75
  MEHP     167.75 ± 11.98^\*^   7.35 ± 0.42       2.65 ± 0.31    0.15 ± 0.00       97.05 ± 9.93           66.25 ± 6.18^\*^    979.75 ± 261.81^\*\*^   105.75 ± 7.23      1.25 ± 0.17    77.25 ± 10.02^\*\*^   10.73 ± 0.34         18.58 ± 1.70    0.58 ± 0.05      146.0 ± 9.20      149.5 ± 22.52        30.75 ± 3.10   143.87 ± 1.79    4.39 ± 0.56       101.72 ± 1.26
  MBuP     146.56 ± 47.90       6.92 ± 0.49       2.17 ± 0.14    0.13 ± 0.05       111.04 ± 32.53^\*\*^   53.17 ± 31.04       732.33 ± 107.35^\*\*^   83.52 ± 10.09      1.67 ± 0.82    58.83 ± 2.46^\*^      10.62 ± 0.41         18.86 ± 2.84    0.5 ± 0.07       153.4 ± 68.29     207.2 ± 124.45       30.8 ± 4.92    141.83 ± 2.70    4.63 ± 0.73       98.65 ± 1.45
  MBeP     163.67 ± 16.77^\*^   7.17 ± 0.39       2.48 ± 0.12    0.13 ± 0.09       129.67 ± 17.35^\*\*^   55.03 ± 20.88       430.59 ± 69.71          89.67 ± 11.99      1.17 ± 0.75    50.05 ± 9.98          10.67 ± 0.57         16.68 ± 2.37    0.58 ± 0.08      226.67 ± 171.73   140.67 ± 69.92       31.17 ± 4.07   142.98 ± 2.19    4.25 ± 0.23       96.82 ± 5.61
  MEP      141.75 ± 21.01       7.04 ± 0.14       2.48 ± 0.15    0.13 ± 0.05       86.54 ± 13.53          65.25 ± 29.34       368.75 ± 52.96          83.25 ± 8.92       0.25 ± 0.05    51.02 ± 9.13          10.43 ± 0.33         19.53 ± 2.74    0.55 ± 0.06      127.75 ± 13.00    120.25 ± 36.51       30.75 ± 3.30   142.95 ± 1.39    4.23 ± 0.65       100.05 ± 4.68
  MMP      145.33 ± 21.79       6.91 ± 0.41       2.53 ± 0.27    0.12 ± 0.04       77.83 ± 10.38          38.07 ± 9.38        439.67 ± 83.57          90.58 ± 9.81       0.33 ± 0.02    55.07 ± 5.37          10.67 ± 0.19         16.85 ± 1.11    0.5 ± 0.00       123.67 ± 22.08    124.33 ± 27.20       31.0 ± 3.29    141.38 ± 1.24    5.54 ± 0.34       99.64 ± 2.26
  PA       137.07 ± 18.38       7.04 ± 0.42       2.46 ± 0.28    0.21 ± 0.00       99.07 ± 16.97          61.53 ± 3.54        405.56 ± 64.85          95.52 ± 2.12       1.03 ± 0.01    57.03 ± 4.24          10.36 ± 0.28         20.27 ± 0.01    0.52 ± 0.05      129.37 ± 1.41     129.54 ± 9.19        34.01 ± 2.83   139.15 ± 1.48    5.09 ± 0.15       98.72 ± 2.69
  -------- -------------------- ----------------- -------------- ----------------- ---------------------- ------------------- ----------------------- ------------------ -------------- --------------------- -------------------- --------------- ---------------- ----------------- -------------------- -------------- ---------------- ----------------- ---------------

Data are means ± SD (n = 6 animals) .

^a^Treated with corn oil.

^\*^Significantly different from the control group at *P*\<0.05.

^\*\*^Significantly different from the control group at *P*\<0.01.

###### 

Urine analysis of Sprague-Dawley rats orally treated with phthalate esters for 2 weeks

  ----------------------- -------- ------ ------ ------ ------- ------ ------ ------ ------ ------ ------ ------ ------ ------ ------- ------
                          CON^a^   DEHP   DBP    DnOP   DEP     BBP    DMP    DIDP   DUP    DINP   MEHP   MBuP   MBeP   MEP    MMP     PA
                                                                                                                                       
  Blood (RBC/μ*l*)        −        −      −      −      −       −      −      250    −      −      −      −      −      −      −       −
  Bilirubin (mg/d*l*)     −        −      −      0.5    −       −      0.5    −      0.5    −      −      −      −      −      −       −
  URO                     −        −      −      −      −       −      −      −      −      −      −      −      −      −      −       −
  Ketone (mg/dl)          10       5      10     10     10      10     10     10     10     5      5      −      5      10     5       10
  Protein (mg/d*l*)       100      30     100    100    100     100    100    100    100    1000   100    100    100    100    30      100
  Nitrite                 \+       −      −      −      \+      −      −      −      −      \+     −      −      −      −      \+      \+
  Glucose (mg/d*l*)       −        −      −      −      −       −      −      −      −      −      −      −      −      −      −       −
  pH                      8        5.5    5.5    5.5    6.5     5      5      5      5      8.5    5      5      5      5      6.5     5.5
  Specific gravity (≥)    1.015    1.03   1.03   1.03   1.025   1.03   1.03   1.03   1.03   1.01   1.03   1.03   1.03   1.03   1.025   1.03
  Leukocytes (WBC/μ*l*)   75       25     10     25     75      25     25     25     75     500    25     75     500    75     75      500
  ----------------------- -------- ------ ------ ------ ------- ------ ------ ------ ------ ------ ------ ------ ------ ------ ------- ------

Data are means ± SD (n = 6 animals) .

^a^Treated with corn oil.

Serum biochemistry.
-------------------

The glucose levels in the DEHP,MEHP and MBeP groups and TP in the DUP group were significantly higher compared with the control group. The AST levels in the DBP-, DUP-, DINP-, MBuP- and MBePtreated groups and the ALT levels in the DEHP, MEHP, and MEP groups were significantly higher than those in the control group. The ALP activity in the serum of the DBP-,DnOP-, DMP-, DUP-, DINP-, MEHP-, and MBuP-treated groups was significantly increased as compared to the control group. However, the serum total cholesterol levels were significantly decreased in DEHP- and DIDP-treated rats as compared to the control rats. However, TG levels were significantly increased in the DINP- and MEHP-treated groups, and serum LDH levels in the DEHP and DEP groups were significantly higher than those in the control group ([Table 3](#T003){ref-type="table"}) .

Urinalysis.
-----------

The value of RBC in animals given the DIDP alone was changed, and the urinary protein level in the animals given DINP alone was also changed. Only the leukocytes in three of the phthalates treatment groups (DINP,MBeP, PA) were changed. The specific gravity of the urine was not changed significantly in any of the groups receiving PEs. There were no inter-group differences in the protein, urobilinogen, glucose, bilirubin and ketone levels in the urine ([Table 4](#T004){ref-type="table"}) .

DISCUSSION
==========

In the present study, PEs showed moderate toxicity when administered orally to male rats for two weeks. We compared the general toxicities of nine phthalate diesters and five phthalate monoesters in Sprague-Dawley rats exposed to 500 mg/kg/day of DBP, DINP and BBP and 250 mg/kg/day of MEHP, MBuP and PA for two weeks. These results exhibited reduced body weight gain, even though there was no difference in food consumption, which suggests that the reduced body weight gain in those groups may have been compound-related. The major findings in the relative organ toxicity were that short term exposure to DEHP, DBP,DnOP and DIDP increased the relative liver weights in the male rats and that there were decreased relative testes weight in DEHP-, DBP-, and MEHP-treated groups as compared to the control. Increased liver weight could be due to peroxisome proliferator activation leading to increased lysosomal activity, which correlates well with the increased serum enzymes like LDH and ALT. Increased liver enzyme activity could result in the leakage of these enzymes into the serum, resulting in increases in the serum levels. Previous work by others has shown that several phthalate monoesters activate PPARα and PPARγ and that lower concentrations of monoesters are required for the activation of PPARα [@B011]; [@B015].

On the other hand, the significantly increased serum triglyceride levels observed in the DINP- and MEHP-treated group indicates an impairment in triglyceride metabolism and enhanced triglyceride storage in the liver, which correlate well with the increased lipid deposits observed in the liver histology in the high-dose DEP-treated groups [@B021]. Cholesterol are synthesized as well as broken down in the liver and the exposure to DEHP at increasing concentration results in higher accumulations of cholesterol in the liver. These results correlate well with an earlier study in which male Sprague-Dawley rats were administered 50 ppm DEP through water; the results showed a significant increase in liver cholesterol levels [@B028]. Impaired cholesterol transport was evident in the higher treated groups due to reduced levels in the serum cholesterol levels. In this study, significant decreases in cholesterol levels were observed in the DEHP- and DIDPtreated groups. Previous studies indicated that steroidogenic acute regulatory protein (StAR) protein plays an important role in the regulation of cholesterol metabolism as well as in steroidogenesis [@B016]; [@B029]. Thus,we suggest that DEHP could affect the StAR protein, hence allowing for the accumulation of excessive cholesterol as observed. Since PPARα is responsible for the regulation of fat metabolism, we suspect that the significantly decreased cholesterol levels in the serum indicate that phthalate-induced toxicity is probably associated with PPARα activation.

PEs have a strong potential for human exposure in the work place and home environment [@B033]. Extensive studies on PE-induced male reproductive toxicity have been reported since [@B025] first reported the DEHP-induced testicular injury in an animal model. DEHP is a well-known reproductive toxicant, and immature rats are more susceptible to DEHP toxicity than mature rats [@B019]; [@B027]; [@B031]. The major target organ for DBP reproductive toxicity in rodents is the testis in general and the seminiferous tubules in particular [@B033]. In a study, the adverse effects on the development of the reproductive system in male offspring were reported in Wistar rats administered BBP by a gavage at 500 mg/kg on Days 15\~17 of pregnancy [@B006]. [@B034] reported that DINP exposures are not associated with any detectable effects on reproductive function. However, these studies did not assess the endpoints of reproductive toxicity, which have been shown to be sensitive with other PEs .

There are no reports on the anti-androgenic activity of DINP, DIDP and DnOP. These are general-purpose plasticizers with a broad range of applications in flexible PVC and are used widely in the toys, construction, and general consumer product markets. Because of the physicochemical similarities between these PEs and DEHP, general exposures to PEs are probably quite similar to exposure to DEHP, but there is little monitoring and reproductive toxicity data.

In conclusion, while the specific mechanism of action remains to be identified, DEHP (and MEHP) , DBP (and MBuP) , BBP (and MBuP and MBeP) , DnOP, DINP, DIDP, DUP and MEP treatments exhibited adverse effects in Sprague-Dawley male rats after orally administered at up to 250 or 500 mg/kg/day. These adverse effects included liver enlargement and reduced testes weight and blood parameters. However, a histological finding study is needed to understanding the exact mechanism of phthalate-mediated toxicity.
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